CA2201725A1 - Composition, device and method for electrotransport agent delivery - Google Patents

Composition, device and method for electrotransport agent delivery

Info

Publication number
CA2201725A1
CA2201725A1 CA002201725A CA2201725A CA2201725A1 CA 2201725 A1 CA2201725 A1 CA 2201725A1 CA 002201725 A CA002201725 A CA 002201725A CA 2201725 A CA2201725 A CA 2201725A CA 2201725 A1 CA2201725 A1 CA 2201725A1
Authority
CA
Canada
Prior art keywords
composition
body surface
electrotransport
agent delivery
applying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002201725A
Other languages
French (fr)
Other versions
CA2201725C (en
Inventor
James A. Huntington
Michel Cormier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
James A. Huntington
Michel Cormier
Alza Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by James A. Huntington, Michel Cormier, Alza Corporation filed Critical James A. Huntington
Publication of CA2201725A1 publication Critical patent/CA2201725A1/en
Application granted granted Critical
Publication of CA2201725C publication Critical patent/CA2201725C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis

Abstract

An electrotransport drug-containing composition is provided. The composition includes a drug to be delivered through a body surface (e.g., skin) of a patient, and a permeation enhancer which is solid or semisolid at temperatures typically encountered during storage of pharmaceuticals (e.g., temperatures up to at least about 25 °C). The composition of the invention may be applied from a device (10) suitable for electrotransport delivery. A method for increasing electrotransport agent delivery rate and reducing body surface resistance relies on applying the composition of the invention to the body surface, and applying an electric current through the composition and the body surface.
CA002201725A 1994-11-14 1995-11-01 Composition, device and method for electrotransport agent delivery Expired - Fee Related CA2201725C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/338,924 1994-11-14
US08/338,924 US5736580A (en) 1994-11-14 1994-11-14 Composition, device, and method for electrotransport agent delivery
PCT/US1995/014091 WO1996014869A1 (en) 1994-11-14 1995-11-01 Composition, device, and method for electrotransport agent delivery

Publications (2)

Publication Number Publication Date
CA2201725A1 true CA2201725A1 (en) 1996-05-23
CA2201725C CA2201725C (en) 2008-06-03

Family

ID=23326715

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002201725A Expired - Fee Related CA2201725C (en) 1994-11-14 1995-11-01 Composition, device and method for electrotransport agent delivery

Country Status (11)

Country Link
US (3) US5736580A (en)
EP (1) EP0789589B1 (en)
JP (1) JP4049389B2 (en)
AT (1) ATE369150T1 (en)
CA (1) CA2201725C (en)
DE (1) DE69535556T2 (en)
DK (1) DK0789589T3 (en)
ES (1) ES2292171T3 (en)
HK (1) HK1000450A1 (en)
PT (1) PT789589E (en)
WO (1) WO1996014869A1 (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6956032B1 (en) * 1986-04-18 2005-10-18 Carnegie Mellon University Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods
US8321013B2 (en) * 1996-01-08 2012-11-27 Impulse Dynamics, N.V. Electrical muscle controller and pacing with hemodynamic enhancement
US8825152B2 (en) 1996-01-08 2014-09-02 Impulse Dynamics, N.V. Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue
US9289618B1 (en) 1996-01-08 2016-03-22 Impulse Dynamics Nv Electrical muscle controller
US7167748B2 (en) 1996-01-08 2007-01-23 Impulse Dynamics Nv Electrical muscle controller
JP4175662B2 (en) 1996-01-08 2008-11-05 インパルス ダイナミクス エヌ．ヴイ． Electric muscle control device
US9713723B2 (en) 1996-01-11 2017-07-25 Impulse Dynamics Nv Signal delivery through the right ventricular septum
US5676648A (en) 1996-05-08 1997-10-14 The Aps Organization, Llp Iontophoretic drug delivery apparatus and method for use
US6385487B1 (en) 1996-05-08 2002-05-07 Biophoretic Therapeutic Systems, Llc Methods for electrokinetic delivery of medicaments
US6119036A (en) * 1997-03-26 2000-09-12 The Board Of Regents Of The University Of Oklahoma Iontophoretic transdermal delivery device
ATE373957T1 (en) 1997-10-09 2007-10-15 Univ Emory METHOD AND DEVICE FOR TRANSDERMAL ADMINISTRATION OF LITHIUM
EP0922467A3 (en) * 1997-12-12 2000-05-24 Takeda Chemical Industries, Ltd. Iontophoretic drug delivery
USRE37796E1 (en) 1997-12-16 2002-07-23 Biophoretic Therapeutic Systems, Llc Methods for iontophoretic delivery of antiviral agents
US6374136B1 (en) * 1997-12-22 2002-04-16 Alza Corporation Anhydrous drug reservoir for electrolytic transdermal delivery device
US6148231A (en) * 1998-09-15 2000-11-14 Biophoretic Therapeutic Systems, Llc Iontophoretic drug delivery electrodes and method
US9101765B2 (en) 1999-03-05 2015-08-11 Metacure Limited Non-immediate effects of therapy
US8019421B2 (en) * 1999-03-05 2011-09-13 Metacure Limited Blood glucose level control
WO2006073671A1 (en) 2004-12-09 2006-07-13 Impulse Dynamics Nv Protein activity modification
US8666495B2 (en) 1999-03-05 2014-03-04 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US8700161B2 (en) 1999-03-05 2014-04-15 Metacure Limited Blood glucose level control
US6477410B1 (en) * 2000-05-31 2002-11-05 Biophoretic Therapeutic Systems, Llc Electrokinetic delivery of medicaments
US7127285B2 (en) * 1999-03-12 2006-10-24 Transport Pharmaceuticals Inc. Systems and methods for electrokinetic delivery of a substance
US6792306B2 (en) 2000-03-10 2004-09-14 Biophoretic Therapeutic Systems, Llc Finger-mounted electrokinetic delivery system for self-administration of medicaments and methods therefor
DE19923427A1 (en) * 1999-05-21 2000-11-23 Lohmann Therapie Syst Lts Device for improved delivery of active agents to skin, useful e.g. for administering opiates, contains agent that increases local skin temperature or blood flow
US7092753B2 (en) * 1999-06-04 2006-08-15 Impulse Dynamics Nv Drug delivery device
US7171263B2 (en) * 1999-06-04 2007-01-30 Impulse Dynamics Nv Drug delivery device
US7190997B1 (en) 1999-06-04 2007-03-13 Impulse Dynamics Nv Drug delivery device
US7069226B1 (en) 1999-07-07 2006-06-27 Synetic, Incorporated Prescription data processing system for determining new therapy starts
JP4879433B2 (en) * 2000-01-13 2012-02-22 エミスフェアー・テクノロジーズ・インク Compounds and compositions for delivering active agents
GB0017999D0 (en) 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
CA2500713C (en) * 2002-10-04 2012-07-03 Photokinetix, Inc. Photokinetic delivery of biologically active substances using pulsed incoherent light
JP2006519663A (en) 2003-03-10 2006-08-31 インパルス ダイナミックス エヌヴイ Apparatus and method for delivering electrical signals for regulating gene expression in heart tissue
US11439815B2 (en) 2003-03-10 2022-09-13 Impulse Dynamics Nv Protein activity modification
US8792985B2 (en) 2003-07-21 2014-07-29 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
US8352031B2 (en) 2004-03-10 2013-01-08 Impulse Dynamics Nv Protein activity modification
US11779768B2 (en) 2004-03-10 2023-10-10 Impulse Dynamics Nv Protein activity modification
US8296162B1 (en) 2005-02-01 2012-10-23 Webmd Llc. Systems, devices, and methods for providing healthcare information
WO2006097934A2 (en) 2005-03-18 2006-09-21 Metacure Limited Pancreas lead
EP1898991B1 (en) 2005-05-04 2016-06-29 Impulse Dynamics NV Protein activity modification
US8380530B2 (en) * 2007-02-02 2013-02-19 Webmd Llc. Personalized health records with associative relationships
US8197844B2 (en) 2007-06-08 2012-06-12 Activatek, Inc. Active electrode for transdermal medicament administration
US20090137925A1 (en) * 2007-11-23 2009-05-28 Divya Cantor Impedance Spectroscopy Cervix Scanning Apparatus and Method
US8862223B2 (en) 2008-01-18 2014-10-14 Activatek, Inc. Active transdermal medicament patch and circuit board for same
WO2011046927A1 (en) * 2009-10-13 2011-04-21 Nupathe,Inc. Transdermal methods and systems for the delivery of rizatriptan
US8934975B2 (en) 2010-02-01 2015-01-13 Metacure Limited Gastrointestinal electrical therapy
JP6243102B2 (en) * 2012-05-01 2017-12-06 株式会社ジェムインターナショナル Patch

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084241A (en) * 1982-09-20 1992-01-28 V-Tech, Inc. Apparatus including a sample petter tube for obtaining reproducible liquid samples of small volume
US5128376A (en) * 1983-07-01 1992-07-07 Nitto Denko Corporation Method for percutaneously administering physiologically active agents using an adjuvant a solvent and a diol moderator
US4605670A (en) * 1984-02-01 1986-08-12 Nitto Electric Industrial Co., Ltd. Method for percutaneously administering metoclopramide
US4722720A (en) * 1985-04-30 1988-02-02 Nhk Spring Co., Ltd. Tension providing device
US4722726A (en) * 1986-02-12 1988-02-02 Key Pharmaceuticals, Inc. Method and apparatus for iontophoretic drug delivery
DE3724691C2 (en) * 1987-07-25 1999-03-18 Konrad Minninger Pharmaceutical agent for the local therapy of flaking skin diseases
ATE91079T1 (en) * 1989-01-25 1993-07-15 Wolff Chem Pharm Gmbh SALICYLIC ACID AGENT AGAINST SCALPING SKIN DISEASES.
US5087242A (en) * 1989-07-21 1992-02-11 Iomed, Inc. Hydratable bioelectrode
US5023085A (en) * 1989-11-29 1991-06-11 Pfizer Inc. Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals
US5149719A (en) * 1990-04-27 1992-09-22 Minnesota Mining And Manufacturing Company Composition for transdermal penetration of medicaments
US5087241A (en) * 1990-07-24 1992-02-11 Empi, Inc. Iontophoresis electrode with reservoir and injection site
ES2072134T3 (en) * 1990-10-29 1995-07-01 Alza Corp IONTOPHORETICAL ELECTRODE TO SUPPLY DRUGS AND METHOD FOR ITS HYDRATION.
US5158537A (en) * 1990-10-29 1992-10-27 Alza Corporation Iontophoretic delivery device and method of hydrating same
ATE169826T1 (en) * 1992-01-21 1998-09-15 Macrochem Corp IONTOPHORETIC IMPROVED DRUG DELIVERY
US5310404A (en) * 1992-06-01 1994-05-10 Alza Corporation Iontophoretic delivery device and method of hydrating same
JPH0616538A (en) * 1992-07-03 1994-01-25 Japan Tobacco Inc Liquid composition for drug absorption for iontophoresis

Also Published As

Publication number Publication date
PT789589E (en) 2007-08-31
DK0789589T3 (en) 2007-12-17
CA2201725C (en) 2008-06-03
JPH10508849A (en) 1998-09-02
WO1996014869A1 (en) 1996-05-23
ES2292171T3 (en) 2008-03-01
ATE369150T1 (en) 2007-08-15
US5736580A (en) 1998-04-07
DE69535556T2 (en) 2008-03-06
JP4049389B2 (en) 2008-02-20
EP0789589B1 (en) 2007-08-08
DE69535556D1 (en) 2007-09-20
US5811465A (en) 1998-09-22
US6057374A (en) 2000-05-02
HK1000450A1 (en) 2008-04-03
EP0789589A1 (en) 1997-08-20

Similar Documents

Publication Publication Date Title
CA2201725A1 (en) Composition, device and method for electrotransport agent delivery
EP1329225A3 (en) Transdermal device containing polyvinylpyrrolidone as solubility enhancer
CA2181742A1 (en) Reduction of skin irritation during electrotransport delivery
CA2010218A1 (en) Therapeutic system for the retarded and controlled transdermal or transmucous administration of active substances
CA2307283A1 (en) Dual shock atrial defibrillation apparatus
CA2218873A1 (en) Electrotransport agent delivery method and apparatus
ITMI961152A0 (en) THERAPEUTIC COMPOSITION FOR THE TRANSDERMAL ADMINISTRATION OF AN ACTIVE INGREDIENT, ESTROGEN OR PROGESTIN OR MIXTURES THEREOF
EP1336600A3 (en) Dimer-selective RXR modulators and methods for their use
WO1999015210A3 (en) Bioadhesive compositions and methods for topical administration of active agents
CA2294927A1 (en) Circumferential ablation device assembly and method
WO1997006789A3 (en) Transdermal drug delivery device having enhanced adhesion
WO2003039620A3 (en) Integrated transdermal drug delivery system
CA2271944A1 (en) Formulation for electrically assisted delivery of lidocaine and epinephrine
CA2202137A1 (en) Composition, device and method for enhanced electrotransport agent delivery
HU9603108D0 (en) Matrix system for the transdermal delivery of ibuprofen, and method for preparing same
NZ502405A (en) Transdermal therapy system (tts) for releasing an active agent into an organism through the skin and method for applying said transdermal therapy system to the skin
PL339736A1 (en) Method of protecting persons against contamination due to inadmissible oral taking toxic ingredients of a transdermal therapeutic system and transdermal therapeutic system containing a contaminating agent
EP0974361A4 (en) Method of using antacid agent and pharmaceutical preparation containing antacid agent
CA2251353A1 (en) Transdermal delivery device for azapirone compounds
CA2218715A1 (en) Electrotransport agent delivery method and apparatus
CA2060994A1 (en) Electrical transdermal drug applicator with counteractor and method of drug delivery
EP1393724A3 (en) Novel formulations for the transdermal administration of fluoxetine

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed